INS and type 2 diabetes mellitus: Despite ongoing evidence of disease progression and weight gain with lifestyle management and metformin therapy, metformin and insulin were the only US Food and Drug Administration (FDA)‐approved treatments for children and adolescents with T2D until 2019.5, 6, 7